01 / Vendor Profile
TEXAS BIOMEDICAL RESEARCH INSTITUTE Federal Contracts and Awards
UEI J4EYPCJDQ1H6 · CAGE 02MD3
Federal contract activity attributed to this vendor identity across FY 2019–FY 2025. Obligations are FPDS accounting transactions, not company revenue.
02 / Federal Business Size
Federal contract market at a glance
Measured consistently across FY 2019–FY 2025.
Across FY 2019–FY 2025, FPDS records attribute $7.48M in net contract obligations to TEXAS BIOMEDICAL RESEARCH INSTITUTE across 26 contract actions. Net obligations include positive obligations and later deobligations recorded during the same period.
03 / Spending Trend
TEXAS BIOMEDICAL RESEARCH INSTITUTE contract spending by year
Annual net obligations show whether recorded federal business expanded or contracted, while actions and customer counts show the breadth of that activity.
Total obligations$4.42M
FY 2025ObligationsHistorical spending range
| Fiscal year | Obligations | Actions | Federal customers | Change |
|---|---|---|---|---|
| FY 2019 | $75.1K | 4 | 2 | — |
| FY 2020 | $213.4K | 5 | 2 | +184.4% |
| FY 2022 | $335.1K | 3 | 3 | +57.0% |
| FY 2023 | $2.27M | 6 | 4 | +577.6% |
| FY 2024 | $160.2K | 4 | 1 | −92.9% |
| FY 2025 | $4.42M | 4 | 2 | +2,662.5% |
04 / Federal Customers
Which federal agencies buy from TEXAS BIOMEDICAL RESEARCH INSTITUTE?
Ranked by net obligations during FY 2019–FY 2025.
| Agency | Code | Obligations | Actions | Vendor share |
|---|---|---|---|---|
| 7505 | $6.82M | 9 | 91.2% | |
| 7524 | $324.9K | 9 | 4.3% | |
| 7523 | $237.9K | 2 | 3.2% | |
| 7529 | $100.0K | 2 | 1.3% | |
| 2100 | -$2.8K | 4 | 0.0% |
05 / Contracting Offices
Which contracting offices buy from TEXAS BIOMEDICAL RESEARCH INSTITUTE?
Ranked by net obligations during FY 2019–FY 2025.
| Office | Code | Agency | Obligations | Actions | Vendor share |
|---|---|---|---|---|---|
| 75A501 | ADMINISTRATION FOR STRATEGIC PREPAREDNESS AND RESPONSE | $6.82M | 9 | 91.2% | |
| 75F401 | FOOD AND DRUG ADMINISTRATION | $324.9K | 9 | 4.3% | |
| 75D301 | CENTERS FOR DISEASE CONTROL AND PREVENTION | $237.9K | 2 | 3.2% | |
| 75N950 | NATIONAL INSTITUTES OF HEALTH | $100.0K | 2 | 1.3% | |
| W911QY | DEPT OF THE ARMY | $0 | 3 | 0.0% | |
| W911SR | DEPT OF THE ARMY | -$2.8K | 1 | 0.0% |
06 / Top NAICS Industries
Which industries define this vendor’s federal work?
| NAICS | Description | Obligations | Actions | Customers | Share |
|---|---|---|---|---|---|
| 541714 | RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) | $6.92M | 11 | 2 | 92.5% |
| 541715 | RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) | $430.9K | 3 | 2 | 5.8% |
| 112990 | ALL OTHER ANIMAL PRODUCTION | $131.8K | 8 | 1 | 1.8% |
| 541712 | RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT BIOTECHNOLOGY) | -$2.8K | 4 | 1 | 0.0% |
07 / Top Product and Service Codes
What products and services does the government buy from this vendor?
| PSC | Description | Obligations | Actions | Customers | Share |
|---|---|---|---|---|---|
| AN13 | HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENT | $6.82M | 9 | 1 | 91.2% |
| 8820 | LIVE ANIMALS, NOT RAISED FOR FOOD | $369.8K | 8 | 2 | 4.9% |
| B529 | SPECIAL STUDIES/ANALYSIS- SCIENTIFIC DATA | $193.0K | 1 | 1 | 2.6% |
| Q301 | MEDICAL- LABORATORY TESTING | $100.0K | 2 | 1 | 1.3% |
| B504 | SPECIAL STUDIES/ANALYSIS- CHEMICAL/BIOLOGICAL | $0 | 2 | 1 | 0.0% |
| AN12 | R&D- MEDICAL: BIOMEDICAL (APPLIED RESEARCH/EXPLORATORY DEVELOPMENT) | -$2.8K | 4 | 1 | 0.0% |
08 / Competition Pattern
How was TEXAS BIOMEDICAL RESEARCH INSTITUTE’s federal work competed?
Competition categories describe the procurement path recorded on the underlying contract actions.
09 / Recent Contract Awards
What contract actions were recorded most recently for TEXAS BIOMEDICAL RESEARCH INSTITUTE?
The latest recorded PIIDs connect this profile to the underlying federal award search.
| Award / PIID | Signed | Obligation | Agency / office | NAICS | PSC |
|---|---|---|---|---|---|
| 75A50123F61002 | Sep 25, 2025 | $4.35M | ADMINISTRATION FOR STRATEGIC PREPAREDNESS AND RESPONSE BARDA - ASPR / DAAPPO / BARDA DCMA | 541714 | AN13 |
10 / Interpreting the Profile
How should you evaluate TEXAS BIOMEDICAL RESEARCH INSTITUTE as a federal contractor?
Read obligations, customers, markets, competition, and individual awards together. A large historical total indicates federal scale, but it does not by itself describe current backlog, commercial revenue, profitability, or future opportunity.
Separate obligations from revenue
FPDS obligations are government accounting actions and may include later deobligations.
Follow customer concentration
Agency and office concentration reveals where the vendor’s federal relationships are strongest.
Test market overlap
NAICS and PSC shares show whether the vendor competes in the same markets as your company.
Inspect the awards
Open the PIIDs to verify dates, offices, classifications, and transaction history.